The doses of estrogen and progestogen used in menopausal hormone therapy may be related to the risk of breast cancer recurrence, according to a new study in the April 6 issue of the Journal of the National Cancer Institute.
Studies Examine Menopausal Hormone Therapy and Risk of Breast Cancer Recurrence
6 April, 2005 - Karolinska Institutet